Cognitive impairment in Parkinson's disease

Area of Science:

• Neurology
• Neuroscience
• Geriatrics

Background:

• Parkinson's disease (PD) is a leading cause of neurodegeneration, frequently associated with cognitive decline and neuropsychiatric issues.
• Dementia in PD can manifest distinctly as Parkinson's disease dementia (PDD) or Dementia with Lewy bodies (DLB), sharing clinical and pathological traits.
• Men are disproportionately affected, with risk factors including advanced age, disease duration, and specific motor symptoms like rigidity and gait impairment.

Purpose of the Study:

• To elucidate the relationship between Parkinson's disease and dementia.
• To identify risk factors and clinical indicators for dementia in Parkinson's disease.
• To outline therapeutic strategies for managing cognitive and neuropsychiatric symptoms in PD.

Main Methods:

• Review of clinical presentations and pathophysiological similarities between PDD and DLB.
• Analysis of risk factors associated with dementia onset in Parkinson's disease.
• Examination of pharmacological interventions for cognitive, motor, and autonomic symptoms.

Main Results:

• Dementia in Parkinson's disease is characterized by cognitive decline and neuropsychiatric symptoms.
• Risk factors include advanced age, disease duration, rigidity, akinesia, postural instability, and falls.
• Tremor-dominant Parkinson's disease is less associated with dementia compared to other motor subtypes.

Conclusions:

• Dementia associated with Parkinson's disease and Dementia with Lewy bodies share significant clinical, pathophysiological, and therapeutic aspects.
• Early recognition of cognitive decline, autonomic dysfunction, and neuropsychiatric symptoms is crucial for effective management.
• Pharmacological treatments, including cholinesterase inhibitors and memantine, alongside adjusted Parkinsonian regimens, can manage dementia symptoms.